Suppr超能文献

IgA 肾病成人患者经保守治疗后的自发缓解。

Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy.

机构信息

Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.

Kidney Center, National Hospital Organization Chiba-East Hospital, Chiba, Japan.

出版信息

PLoS One. 2021 May 27;16(5):e0251294. doi: 10.1371/journal.pone.0251294. eCollection 2021.

Abstract

BACKGROUND

There are few studies describing the clinical course and spontaneous remission of IgA nephropathy (IgAN) in adult patients receiving conservative treatment.

METHOD

Data from 62 adult patients with biopsy-diagnosed IgAN, who received conservative treatment at least 5 years prior, were retrospectively investigated. No patients received corticosteroids, other immunosuppressants, or tonsillectomy. Remission of proteinuria and hematuria were defined as proteinuria <0.3 g/gCr and urine red blood cells (RBC) <5 / high power field (HPF) on three consecutive urinalyses obtained during an observation period of ≥6 months.

RESULT

Thirty-eight (61.3%) patients had remission of hematuria, 24 (38.7%) had remission of proteinuria, and 19 (30.6%) had remission of both. Remission rates increased in patients with proteinuria <0.5 g/g Cr at diagnosis. The median time to remission of hematuria was 2.8 years and that of proteinuria was 2.6 years. Patients who showed renal function decline (defined as 30% decline of estimated glomerular filtration rate [eGFR] from baseline) were older, had significantly lower eGFR, and higher proteinuria at diagnosis. Two patients with preserved renal function and normal proteinuria at diagnosis experienced renal function decline. Renal function did not decline within 3 years of diagnosis in patients with proteinuria <1 g/gCr at diagnosis.

CONCLUSIONS

Relatively high rates of spontaneous remission were observed. Remission of both hematuria and proteinuria were frequent within 3 years after diagnosis, and renal function was well preserved during this period. These data indicate that it is rational to use conservative treatment for 3 years after the diagnosis instead of aggressive treatments.

摘要

背景

描述接受保守治疗的成人 IgA 肾病(IgAN)患者的临床病程和自发缓解的研究较少。

方法

回顾性调查了 62 名接受活检诊断的 IgAN 且接受保守治疗至少 5 年的成年患者的数据。没有患者接受皮质类固醇、其他免疫抑制剂或扁桃体切除术。蛋白尿和血尿缓解定义为连续 3 次尿分析中蛋白尿<0.3 g/gCr 和尿红细胞(RBC)<5 /高倍视野(HPF),观察期至少为 6 个月。

结果

38 例(61.3%)患者血尿缓解,24 例(38.7%)蛋白尿缓解,19 例(30.6%)两者均缓解。诊断时蛋白尿<0.5 g/gCr 的患者缓解率较高。血尿缓解的中位时间为 2.8 年,蛋白尿缓解的中位时间为 2.6 年。出现肾功能下降(定义为从基线估计肾小球滤过率 [eGFR] 下降 30%)的患者年龄较大,eGFR 明显较低,且诊断时蛋白尿较高。2 名诊断时肾功能正常且蛋白尿正常的患者出现肾功能下降。诊断时蛋白尿<1 g/gCr 的患者在 3 年内肾功能未下降。

结论

观察到较高的自发缓解率。诊断后 3 年内血尿和蛋白尿均频繁缓解,在此期间肾功能得到很好的保护。这些数据表明,在诊断后 3 年内使用保守治疗而不是积极治疗是合理的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ac2/8159003/101dd0f1dffc/pone.0251294.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验